<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04763538</url>
  </required_header>
  <id_info>
    <org_study_id>ID 2020-02852</org_study_id>
    <nct_id>NCT04763538</nct_id>
  </id_info>
  <brief_title>Quality and Outcome Measurements of Urological Patients</brief_title>
  <official_title>Quality and Outcome Measurements of Urological Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Centre Biel/Bienne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospectively, all available parameters of urologic patients treated at the study sites will&#xD;
      be acquired and stored in multilayered databases. Upon a given samples size, neuronal&#xD;
      networks will be trained to define clinical endpoints. Beside uro-oncological patients also&#xD;
      patients with other urological diseases will be enrolled.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2028</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Disease specific primary endpoint</measure>
    <time_frame>4-5 years</time_frame>
    <description>Neuronal networks will be trained to define the respective endpoints for the diseases</description>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Urologic Diseases</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Patients are treated according to the standard of care for each individual disease.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Entire patient population that is treated at the study sites&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients treated at the study sites, signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No consent to record medical history&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roland Seiler, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Urology, University Hospital Bern</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roland Seiler, Prof.</last_name>
    <phone>+41316321349</phone>
    <email>Roland.Seiler@insel.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Roland Seiler</name>
      <address>
        <city>Biel</city>
        <zip>2501</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Roland Seiler, Prof.</last_name>
      <phone>+41 32 324 24 24</phone>
      <email>r_seiler@gmx.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 16, 2021</study_first_submitted>
  <study_first_submitted_qc>February 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2021</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urologic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>In this trial, the investigators will record complete patient data in our multilayered databases. They will be used to train neuronal networks. Latter can be shared with researchers, the multilayered databases will not be shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

